home / stock / mycof / mycof news

MYCOF News and Press, New Age Brands From 03/01/21

Stock Information
Company Name: New Age Brands
Stock Symbol: MYCOF
Market: OTC
Website: mydecine.com
Menu
MYCOF MYCOF Quote MYCOF Short MYCOF News MYCOF Articles MYCOF Message Board
Get MYCOF Alerts

News, Short Squeeze, Breakout and More Instantly...
MYCOF - "Buzz on the Street" Show: Mydecine Innovations (OTC: MYCOF) (CSE: MYCO) Export of Psilocybin

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain.” Mydecine I...
MYCOF - Breaking News: Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Mydecine Innovations Group(OTC: MYCOF) (CSE: MYCO) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma company in the life sciences category committed to the research and development, production, and acceptance of alternative nature-sourced...

MYCOF - Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

DENVER – March 1, 2021 — Mydecine Innovations Group™(CSE:MYCO)(OTC:MYCOF)(FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma company in the life sciences category committed to the research and development, productio...

MYCOF - First Movers in the Psychedelics Space Position Themselves as Industry Leaders

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – February 25, 2021 – The emergence of psychedelics as a mental health solution and as a legitimate industry has been one of the most radical market developments that we have seen in d...
MYCOF - Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta

Partnership Supports Mydecine’s Drug Development & Clinical Trials Pipeline Provides Update on Debt Settlement *NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DENVER, Feb. 24, 2021 (GLO...

MYCOF - Ongoing Public Mental Health Crisis Calls For Innovative Treatments

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – February 18, 2021 – The ongoing pandemic has inflamed and highlighted a separate but very connected public health crisis that has been growing all around the world for decades. Rates...

MYCOF - Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap's Mental Health Technology

DENVER, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc., ( CSE:MYCO ) ( OTC:MYCOF ) ( FSE:0NFA ) ("Mydecine" or the "Company") is pleased to announce that its subsidiary Mindleap Health (“Mindleap”), a digital health platform and the ...
MYCOF - Mydecine Innovations Group Announces Closing of $17,250,000 Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

*NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company c...

MYCOF - Mydecine Innovations Group Files Final Prospectus in Connection with Bought Deal Offering of Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“ Mydecine ” or the “ Company’ ), an emerging biopharma and life science...

MYCOF - Mydecine Innovations Group Files Amended and Restated Financial Statements

Mydecine Innovations Group Inc. (the “ Company ”) (CSE:MYCO | OTC:MYCOF) (FSE: 0NFA) announces it has filed amended and restated unaudited condensed interim consolidated financial statements for the nine-month period ended September 30, 2020 (the “ Restated St...
Previous 10 Next 10